Moreover, experimental studies have showed that administration of IL-1 receptor antagonist decreases severity of experimental acute pancreatitis [70], whereas overexpression of IL-1β in transgenic mice results in chronic pancreatitis [71]. Here, IL1B is linked to acute pancreatitis.